These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 5158660)
1. [Use of serum and blood from foot-and-mouth disease convalescents]. Lysenko IP; Panasenko AK; Konarzhevskiĭ KE Veterinariia; 1971 May; 5():47-9. PubMed ID: 5158660 [No Abstract] [Full Text] [Related]
2. The effect of a synthetic anionic polymer (pyran) on the development of foot-and-mouth disease in guinea-pigs, cattle and pigs. Sellers RF; Herniman KA; Hawkins CW Res Vet Sci; 1972 Jul; 13(4):339-41. PubMed ID: 5072576 [No Abstract] [Full Text] [Related]
3. Early response of cattle and swine to inactivated foot-and-mouth disease vaccine. Graves JH; McKercher PD; Farris HE; Cowan KM Res Vet Sci; 1968 Jan; 9(1):35-40. PubMed ID: 5689040 [No Abstract] [Full Text] [Related]
4. [Practical experiences in the immunization of pigs against foot-and-mouth disease]. Kamphans S; Schneider B Dtsch Tierarztl Wochenschr (1946); 1963 Jan; 70(1):1-3. PubMed ID: 5896721 [No Abstract] [Full Text] [Related]
5. [A method for obtaining defibrinated blood of convalescents in foot-and-mouth disease]. Samushenok VI; Khegaĭ TA Veterinariia; 1966 Sep; 43(9):91-2. PubMed ID: 6011490 [No Abstract] [Full Text] [Related]
6. Vaccination against foot-and-mouth disease. Morgan DO; Moore DM; McKercher PD Prog Clin Biol Res; 1980; 47():169-78. PubMed ID: 6259663 [No Abstract] [Full Text] [Related]
7. [On testing the efficiency of foot-and-mouth disease hyperimmune serum in guinea pigs by injecting myotropic foot-and-mouth disease virus strains]. Bengelsdorff HJ Zentralbl Veterinarmed B; 1965 Jul; 12(4):340-50. PubMed ID: 4283976 [No Abstract] [Full Text] [Related]
8. [Immunological value of pig convalescent blood and its significance in the prevention of foot-and-mouth disease]. Cioloca T; Marschang F; Schäffer F Zentralbl Veterinarmed B; 1971 May; 18(3):190-6. PubMed ID: 5105737 [No Abstract] [Full Text] [Related]
9. [Apropos of the conclusions (Point I, Section E) of the 11th conference of the Permanent Commission on Foot-and-Mouth Disease of the International Office of Epizootic Diseases in Paris]. Röhrer H Bull Off Int Epizoot; 1966; 65(11):1921-8. PubMed ID: 5994040 [No Abstract] [Full Text] [Related]
10. [Relationship between the stage of infection in pigs infected with foot-and-mouth disease and the passive protection given to mice by their immune sera]. Lübke A Zentralbl Veterinarmed B; 1967 Oct; 14(6):553-61. PubMed ID: 5628222 [No Abstract] [Full Text] [Related]
11. [The use of plastic bags for collecting the blood of convalescents]. Ratner LS; Bykov IA; Kruglov NE Veterinariia; 1966 Sep; 43(9):93-4. PubMed ID: 6011492 [No Abstract] [Full Text] [Related]
12. Enhanced immunogenicity of multiple-epitopes of foot-and-mouth disease virus fused with porcine interferon alpha in mice and protective efficacy in guinea pigs and swine. Du Y; Li Y; He H; Qi J; Jiang W; Wang X; Tang B; Cao J; Wang X; Jiang P J Virol Methods; 2008 Apr; 149(1):144-52. PubMed ID: 18294705 [TBL] [Abstract][Full Text] [Related]
13. Protection of guinea pigs and swine by a recombinant adenovirus expressing O serotype of foot-and-mouth disease virus whole capsid and 3C protease. Lu Z; Bao H; Cao Y; Sun P; Guo J; Li P; Bai X; Chen Y; Xie B; Li D; Liu Z; Xie Q Vaccine; 2008 Dec; 26 Suppl 6():G48-53. PubMed ID: 19178894 [TBL] [Abstract][Full Text] [Related]
14. Comparison of immune responses against foot-and-mouth disease virus induced by fusion proteins using the swine IgG heavy chain constant region or beta-galactosidase as a carrier of immunogenic epitopes. Li G; Chen W; Yan W; Zhao K; Liu M; Zhang J; Fei L; Xu Q; Sheng Z; Lu Y; Zheng Z Virology; 2004 Oct; 328(2):274-81. PubMed ID: 15464847 [TBL] [Abstract][Full Text] [Related]
15. [Interference of viruses with foot-and-mouth disease]. Gizatullin KhG; Gumerov NK Veterinariia; 1969 Sep; 9():23-4. PubMed ID: 5392424 [No Abstract] [Full Text] [Related]
16. [Preparation of foot-and-mouth disease diagnostic serum with the use of rabbit tissue antigen]. Zagorodnov MV; Elagina VB; Prostakova NV Veterinariia; 1967 Jan; 44(1):28-9. PubMed ID: 4300576 [No Abstract] [Full Text] [Related]
17. [The efficacy of foot and mouth disease vaccines after long- term storage]. Wittmann G Berl Munch Tierarztl Wochenschr; 1980 Jan; 93(2):33-4. PubMed ID: 6248022 [No Abstract] [Full Text] [Related]
18. [Control of foot and mouth disease. Conclusions and recommendations of Working Group for Foot and Mouth Disease]. Jorna T; Benedictus G; Bouma A; Breeuwsma AJ; Franken P; Plaisier AJ; Sutmöller P; Tijdschr Diergeneeskd; 2003 Mar; 128(5):146-8. PubMed ID: 12645322 [No Abstract] [Full Text] [Related]
19. [Nature, extent and causes of vaccination complications following foot-and-mouth disease vaccination from 1967 to 1968 in Bavaria]. Mayr A; Ringseisen J; Baljer G; Bibrack B; Wallner J; Zimmer H Zentralbl Veterinarmed B; 1969 Aug; 16(6):488-511. PubMed ID: 5349563 [No Abstract] [Full Text] [Related]
20. Toxic effect of foot-and-mouth disease immune cattle sera injected subcutaneously in guinea pigs. MICHELSEN E; JOHNSON M Acta Pathol Microbiol Scand; 1951; 28(3):226-33. PubMed ID: 14856729 [No Abstract] [Full Text] [Related] [Next] [New Search]